Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
SNTI on Nasdaq
Shares outstanding
30,025,160
Price per share
$1.02
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
5,569,956
Total reported value
$5,792,757
% of total 13F portfolios
0%
Share change
-75,196
Value change
-$124,561
Number of holders
14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Celadon Partners SPV 24 45% 0% $14,186,888 +$112,225 13,511,322 +0.8% Celadon Partners SPV 24 19 Jan 2026
New Enterprise Associates 15, L.P. 14% $11,968,700 3,775,615 New Enterprise Associates 15, L.P. 06 Mar 2025
Nantahala Capital Management, LLC 8.1% -19% $7,037,400 +$5,422,973 2,220,000 +336% Nantahala Capital Management, LLC 31 Mar 2025
ARMISTICE CAPITAL, LLC 5% -50% $4,564,204 +$2,865,052 1,439,812 +169% Armistice Capital, LLC 31 Mar 2025
Nantahala Capital Partners Limited Partnership 1.9% -67% $1,592,925 +$637,170 502,500 +67% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 31 Mar 2025

As of 31 Dec 2025, 14 institutional investors reported holding 5,569,956 shares of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI). This represents 19% of the company’s total 30,025,160 outstanding shares.

Top 18 Institutional Shareholders

The largest institutional shareholders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) together control 19% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NEA Management Company, LLC 13% 3,775,615 0% 0.2% $3,926,640
Nantahala Capital Management, LLC 3% 888,000 0% 0.06% $923,520
VANGUARD GROUP INC 2.1% 628,697 +2% 0% $653,845
GEODE CAPITAL MANAGEMENT, LLC 0.48% 144,797 -5.3% 0% $150,594
JANE STREET GROUP, LLC 0.13% 38,427 0% $39,964
MSOP GP, L.L.C. 0.12% 35,737 0% 0.01% $37,166
BlackRock, Inc. 0.08% 23,384 +3.5% 0% $24,319
NORTHERN TRUST CORP 0.06% 16,778 +2.9% 0% $17,449
STATE STREET CORP 0.03% 10,010 0% 0% $10,410
UBS Group AG 0.02% 4,529 0% $4,710
Tower Research Capital LLC (TRC) 0.01% 3,411 +97% 0% $3,547
SBI Securities Co., Ltd. 0% 336 0% 0% $349
MORGAN STANLEY 0% 160 0% 0% $166
BANK OF AMERICA CORP /DE/ 0% 75 -83% 0% $78
XTX Topco Ltd 0% 0 -100% $0
CITADEL ADVISORS LLC 0% 0 -100% $0
TWO SIGMA INVESTMENTS, LP 0% 0 -100% $0
CITIGROUP INC 0% 0 -100% $0

Institutional Holders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,569,956 $5,792,757 -$124,561 $1.04 14
2025 Q3 5,609,415 $7,909,282 -$2,933,647 $1.41 15
2025 Q2 6,484,682 $13,682,488 +$1,724,635 $2.11 14
2025 Q1 5,663,433 $19,029,155 +$16,777,530 $3.36 14
2024 Q4 667,184 $2,341,958 -$330,207 $3.51 14
2024 Q3 763,984 $1,726,485 +$1,717,436 $2.26 12